Since functional inactivation of Smad4 (13–14) and aberrant expression of β-catenin (15) play pivotal roles in gastric carcinogenesis, we examined whether Tob1 could modulate the expression of Smad4 and β-catenin, thereby preventing gastric cancer progression. The gene discussed is TOB1; the disease is gastric cancer.